Genzum Life Sciences announces Dovi Frances to its Board after SG, LLC increased its investment by up to $20M
– USA, CA – SG, LLC announced today that the firm’s Alternative Investments Division has increased its investment in Genzum Life Sciences by up to $20MM, with a portion of the investment reserved for additional growth capital.…